Ginkgo Biloba (Ginkgo biloba)

Ginkgo biloba contains flavonoids and terpenoids that enhance cerebral blood flow and provide neuroprotection. Clinical studies demonstrate significant cognitive improvements in Alzheimer's patients and enhanced daily living activities in dementia.

Origin & History

Ginkgo biloba is derived from the leaves of the Ginkgo biloba tree, a living fossil native to China used in traditional medicine for centuries. The standardized extract (e.g., EGb 761) is produced by extracting dried leaves with acetone and water, followed by purification to remove impurities like ginkgolic acids, resulting in an herbal extract rich in flavonoids and terpenoids.

Historical & Cultural Context

Ginkgo biloba has been used in Chinese traditional medicine for centuries for cognitive and circulatory issues. Modern standardized extracts like EGb 761 have been applied long-term for vascular dementia and Alzheimer's disease, bridging ancient wisdom with contemporary clinical applications.

Health Benefits

• Improves cognitive function in Alzheimer's patients (Strong evidence: meta-analysis of 7 RCTs, N=939, showing RR=1.98 for cognitive improvement)
• Enhances activities of daily living in dementia (Moderate evidence: meta-analysis of 4 RCTs, N=782, showing significant ADL improvements p=0.01)
• Increases walking distance in peripheral arterial disease (Moderate evidence: meta-analysis of 5 RCTs showing effect size=0.75, P<0.001)
• Improves quality of life in mild dementia patients (Moderate evidence: 4 RCTs showing QoL improvements p=0.02)
• Reduces neuropsychiatric symptoms in dementia (Moderate evidence: multiple RCTs showing NPI/SKT improvements with 240mg/day)

How It Works

Ginkgo biloba's flavonoids (quercetin, kaempferol) and terpenoids (ginkgolides A, B, C) enhance cerebral blood flow by inhibiting platelet-activating factor and improving endothelial function. The compounds also provide neuroprotection through antioxidant activity and modulation of neurotransmitter systems including acetylcholine and dopamine.

Scientific Research

Multiple meta-analyses support Ginkgo biloba for cognitive impairment, with a 2020 analysis of 7 RCTs (N=939, PMID: 32658034) showing nearly double the cognitive improvement versus placebo. A 2023 meta-analysis of 18 RCTs (N=1,642, PMID: 36960422) demonstrated that combining Ginkgo with donepezil was superior to donepezil alone (RR=1.23), while a 2015 analysis of 21 RCTs (N=2,608, PMID: 26268332) found significant MMSE improvements.

Clinical Summary

A meta-analysis of 7 randomized controlled trials (N=939) showed ginkgo biloba nearly doubled the likelihood of cognitive improvement in Alzheimer's patients (RR=1.98). Another meta-analysis of 4 RCTs (N=782) demonstrated significant improvements in activities of daily living among dementia patients (p=0.01). Most studies used standardized EGb 761 extract at 120-240mg daily for 12-52 weeks, showing moderate to strong evidence for cognitive benefits.

Nutritional Profile

Ginkgo biloba leaf extract is not a significant source of macronutrients (negligible protein <1%, fats <1%, carbohydrates minimal in standardized extracts). Its profile is defined by standardized bioactive compounds: **Flavonoid glycosides (24% in EGb 761 standardized extract)** — primarily quercetin glycosides (~9-10 mg/g), kaempferol glycosides (~8-9 mg/g), and isorhamnetin glycosides (~2-3 mg/g); these are hydrolyzed to aglycones post-absorption with moderate bioavailability (~70-80% for quercetin derivatives). **Terpene lactones (6% in EGb 761)** — ginkgolides A, B, C, J (total ~3.1-3.4 mg/g) and bilobalide (~2.6-2.9 mg/g); ginkgolide B is the most pharmacologically active PAF antagonist; oral bioavailability of ginkgolides ~80%, bilobalide ~72%. **Ginkgolic acids** — potentially toxic alkylphenols, regulated to <5 ppm (<5 µg/g) in quality extracts (USP/EMA standard). **Proanthocyanidins** — present at ~7% in crude leaf, reduced in standardized extracts; include catechin and epicatechin oligomers. **Other polyphenols** — biflavonoids (amentoflavone, bilobetin, ginkgetin) at ~0.2-0.5 mg/g; notable as CYP3A4 inhibitors but poorly bioavailable (~20-30%) due to low solubility. **Minerals** — trace amounts: potassium (~3.2 mg/g dry leaf), calcium (~8.1 mg/g dry leaf), magnesium (~2.1 mg/g dry leaf); negligible in concentrated extracts. **Vitamins** — minimal: trace vitamin C (~0.5-1.2 mg/g in fresh leaf, degraded in extract processing), trace beta-carotene. **Fiber** — crude leaf contains ~15-18% dietary fiber, essentially absent in standardized liquid/tablet extracts. Standard clinical dose of 120-240 mg EGb 761 extract delivers approximately 28.8-57.6 mg flavonoid glycosides and 7.2-14.4 mg terpene lactones. Bioavailability is enhanced by lipid co-administration for terpene lactones; Tmax for ginkgolide B ~2 hours, half-life ~4-4.5 hours; Tmax for flavonol aglycones ~1.5-2.5 hours post-hydrolysis.

Preparation & Dosage

Standardized EGb 761 extract (24% flavone glycosides, 6% terpene lactones): 120-240mg daily for dementia/Alzheimer's disease, typically administered as 240mg/day for mild dementia or 120mg/day for longer-term use. For peripheral artery disease: 120mg/day. For neuropsychiatric symptoms: 160-240mg/day over 24 weeks. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Donepezil, Omega-3 fatty acids, Phosphatidylserine, Vitamin E, B-complex vitamins

Safety & Interactions

Ginkgo biloba may increase bleeding risk and should be avoided with anticoagulants like warfarin and aspirin. Common side effects include headache, dizziness, and gastrointestinal upset in 2-10% of users. The supplement may interact with seizure medications and should be discontinued 2 weeks before surgery. Pregnancy and breastfeeding safety data is insufficient, making use inadvisable during these periods.